CBP/p300-IN-22
CBP/p300-IN-22 is a selective inhibitor of the CBP/EP300 bromodomain, with an IC50 of 4 nM. It exhibits high selectivity for BRD4 (1) and reduces cytokine expression induced by TNF-α as well as subsequent immune cell recruitment by inhibiting NF-κB signaling, demonstrating anticancer properties. This compound is applicable for research into rheumatoid arthritis (RA) and other TNF-α-mediated inflammatory diseases.
Product Specifications
Field of Research
Epigenetics & Chromatin, Signal Transduction
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
134167 100 µg
TADA2L (TADA2A, Transcriptional Adapter 2-alpha, Transcriptional Adapter 2-like, ADA2-like Protein, FLJ12705, KL04P)
Sign In for Pricing
View Details 244457-AP 100 µL
CDC2L6 (Cell Division Cycle 2-like 6 (CDK8-like), CDK11, KIAA1028, bA346C16.3) (AP) discontinued
Sign In for Pricing
View Details